![](/pharma/pharma_sep19/contents/656424/1_content.480_0_1.jpg)
Regulators are beginning to embrace real-world data when assessing new drugs
![](/pharma/pharma_sep19/contents/656415/2_content.480_0_1.jpg)
A look back at breakthrough achievements of immunologist Dr Teruko Ishizaka
![](/pharma/pharma_sep19/contents/656416/3_content.480_0_1.jpg)
Patients in the UK are banding together to access a costly cystic fibrosis treatment
![](/pharma/pharma_sep19/contents/656417/4_content.512_0_1.jpg)
A new study explores key questions about attitudes to psychiatric drugs in the UK
![](/pharma/pharma_sep19/contents/656418/5_content.480_0_1.jpg)
What is being done to address the problem of overusing antibiotics in animals?
![](/pharma/pharma_sep19/contents/656419/6_content.480_0_1.jpg)
A pan-European body is tackling the unknowns of medication in pregnancy
![](/pharma/pharma_sep19/contents/656420/7_content.720_0_1.jpg)
How does Switzerland promote the creation of new biotech companies?
![](/pharma/pharma_sep19/contents/656421/8_content.480_0_1.jpg)
An anti-cancer agent found in sea sponges has proven its potency in mouse models
![](/pharma/pharma_sep19/contents/656422/9_content.720_0_1.jpg)
Life sciences firms must redouble their efforts to ensure IMDP compliance by 2021
![](/pharma/pharma_sep19/contents/656423/10_content.480_0_1.jpg)
Why does global labelling management continue to cause problems?